Search
Patexia Research
Case number 3:18-cv-00276

Celltrion, Inc. et al v. Genentech, Inc. et al > Summary

Court Case Number 3:18-cv-00276

Filing Date Jan 11, 2018

Termination Date Jun 11, 2018

Court California Northern District Court

Status Judgment - Other

JudgesJeffrey S. White

Plaintiff Attorneys

37

Celltrion
Attorney Name: Elaine H. Blais
Goodwin Procter LLP

TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Elaine H. Blais
Goodwin Procter LLP

Teva Pharmaceuticals
Attorney Name: Elaine H. Blais
Goodwin Procter LLP

Celltrion Healthcare Co., Ltd.
Attorney Name: Robert Vaughan Cerwinski
Goodwin Procter LLP

Celltrion
Attorney Name: Robert Vaughan Cerwinski
Goodwin Procter LLP

TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Robert Vaughan Cerwinski
Goodwin Procter LLP

Teva Pharmaceuticals
Attorney Name: Robert Vaughan Cerwinski
Goodwin Procter LLP

Celltrion Healthcare Co., Ltd.
Attorney Name: Eamonn J. Gardner
Cooley LLP

Celltrion
Attorney Name: Eamonn J. Gardner
Cooley LLP

TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Eamonn J. Gardner
Cooley LLP

Teva Pharmaceuticals
Attorney Name: Eamonn J. Gardner
Cooley LLP

Celltrion
Attorney Name: Elizabeth J. Holland
Goodwin Procter LLP

TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Elizabeth J. Holland
Goodwin Procter LLP

Teva Pharmaceuticals
Attorney Name: Elizabeth J. Holland
Goodwin Procter LLP

Celltrion Healthcare Co., Ltd.
Attorney Name: Elizabeth J. Holland
Goodwin Procter LLP

Celltrion Healthcare Co., Ltd.
Attorney Name: Daniel J. Knauss
Cooley LLP

Celltrion
Attorney Name: Daniel J. Knauss
Cooley LLP

TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Daniel J. Knauss
Cooley LLP

Teva Pharmaceuticals
Attorney Name: Daniel J. Knauss
Cooley LLP

Celltrion Healthcare Co., Ltd.
Attorney Name: Michelle S. Rhyu
Cooley LLP

Celltrion
Attorney Name: Michelle S. Rhyu
Cooley LLP

TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Michelle S. Rhyu
Cooley LLP

Teva Pharmaceuticals
Attorney Name: Michelle S. Rhyu
Cooley LLP

Celltrion Healthcare Co., Ltd.
Attorney Name: Daryl L. Wiesen
Goodwin Procter LLP

Celltrion
Attorney Name: Daryl L. Wiesen
Goodwin Procter LLP

TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Daryl L. Wiesen
Goodwin Procter LLP

Teva Pharmaceuticals
Attorney Name: Daryl L. Wiesen
Goodwin Procter LLP

Celltrion Healthcare Co., Ltd.
Attorney Name: Huiya Wu
Goodwin Procter LLP

Celltrion
Attorney Name: Huiya Wu
Goodwin Procter LLP

TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Huiya Wu
Goodwin Procter LLP

Teva Pharmaceuticals
Attorney Name: Huiya Wu
Goodwin Procter LLP

Celltrion
Attorney Name: Natasha E. Daughtrey
Goodwin Procter LLP

Celltrion Healthcare Co., Ltd.
Attorney Name: Natasha E. Daughtrey
Goodwin Procter LLP

Teva Pharmaceuticals
Attorney Name: Natasha E. Daughtrey
Goodwin Procter LLP

TEVA PHARMACEUTICALS INTERNATIONAL GmbH
Attorney Name: Natasha E. Daughtrey
Goodwin Procter LLP

Celltrion
Attorney Name: Sehoon Kim
Celltrion Healthcare Co., Ltd.

Cause

28:2201 Declaratory Judgement

Related Patents

Doc No Title Issue date
09714293 Production of proteins in glutamine-free cell culture media Jul 25, 2017
09504744 Treatment of diffuse large-cell lymphoma with anti-CD20 antibody Nov 29, 2016
09487809 Decreasing lactate level and increasing polypeptide production by downregulating the expression of lactate dehydrogenase and pyruvate dehydrogenase kinase Nov 8, 2016
09428766 Protein expression from multiple nucleic acids Aug 30, 2016
09428548 Enhanced protein purification through a modified protein A elution Aug 30, 2016
09296821 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibodies Mar 29, 2016
09080183 Promoter Jul 14, 2015
09047438 Chromatography equipment characterization Jun 2, 2015
08822655 Pre-filtration adjustment of buffer solutes Sep 2, 2014
08821873 Treatment of diffuse large-cell lymphoma with anti-CD20 antibody Sep 2, 2014
08771988 Protein expression from multiple nucleic acids Jul 8, 2014
08710196 Protein purification Apr 29, 2014
08633302 Variable tangential flow filtration Jan 21, 2014
08574869 Prevention of disulfide bond reduction during recombinant production of polypeptides Nov 5, 2013
08557244 Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody Oct 15, 2013
08545843 Treatment of vasculitis Oct 1, 2013
08512983 Production of proteins in glutamine-free cell culture media Aug 20, 2013
08460895 Method for producing recombinant proteins with a constant content of pCO2 in the medium Jun 11, 2013
08357301 Chromatography equipment characterization Jan 22, 2013
08329172 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody Dec 11, 2012
08206711 Treatment of chronic lymphocytic leukemia using anti-CD20 antibodies Jun 26, 2012
08044017 Protein purification Oct 25, 2011
07976838 Therapy of autoimmune disease in a patient with an inadequate response to a TNF-α inhibitor Jul 12, 2011
07923221 Methods of making antibody heavy and light chains having specificity for a desired antigen Apr 12, 2011
07820161 Treatment of autoimmune diseases Oct 26, 2010
07807799 Reducing protein A leaching during protein A affinity chromatography Oct 5, 2010
07682612 Treatment of hematologic malignancies associated with circulating tumor cells using chimeric anti-CD20 antibody Mar 23, 2010
07485704 Reducing protein A leaching during protein A affinity chromatography Feb 3, 2009
07390660 Methods for growing mammalian cells in vitro Jun 24, 2008
06716602 Metabolic rate shifts in fermentations expressing recombinant proteins Apr 6, 2004
06620918 Separation of polypeptide monomers Sep 16, 2003
06610516 Cell culture process Aug 26, 2003
06586206 Methods for making recombinant proteins using apoptosis inhibitors Jul 1, 2003
06489447 Protein purification Dec 3, 2002
06455043 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody Sep 24, 2002
06417335 Protein purification Jul 9, 2002
06331415 Methods of producing immunoglobulins, vectors and transformed host cells for use therein Dec 18, 2001
Menu